Journal articles

2023

Cordtz, R., Kristensen, S., Westermann, R., Duch, K., Pearce, F., Lindhardsen, J., Torp-Pedersen, C., Andersen, M. P., & Dreyer, L. (2023). COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis. Rheumatology, 62(1), 77–88. https://doi.org/10.1093/rheumatology/keac241

Gumber, L., Jackson, H., Gomez, N., Hopkins, G., Tucis, D., Chakravorty, M., Tighe, P., Grainge, M., Rutter, M., Ferraro, A., Power, S., Pradère, M.-J., Lanyon, P. C., Pearce, F. A., & Fairclough, L. (2023). Antibody response to four doses of SARS-CoV-2 vaccine in rare autoimmune rheumatic diseases: an observational study. Rheumatology Advances in Practice, rkad097. https://doi.org/10.1093/rap/rkad097

Odingo, M., Rutter, M., Bowley, J., Peach, E. J., Lanyon, P. C., Grainge, M. J., Stillwell, P., McPhail, S., Bythell, M., Aston, J., Stevens, S., McCormack, R., Brogan, P., & Pearce, F. A. (2023). The incidence of Kawasaki disease using hospital admissions data for England 2006-2021. Rheumatology. https://doi.org/10.1093/rheumatology/kead051

Pearce, F. A., Lim, S. H., Bythell, M., Lanyon, P., Hogg, R., Taylor, A., Powter, G., Cooke, G. S., Ward, H., Chilcot, J., Thomas, H., Mumford, L., McAdoo, S. P., Pettigrew, G. J., Lightstone, L., & Willicombe, M. (2023). Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY. The Lancet Rheumatology, 5(8), e461–e473. https://doi.org/10.1016/S2665-9913(23)00160-1

Rutter, M., Lanyon, P. C., Grainge, M. J., Hubbard, R., Bythell, M., Stilwell, P., Aston, J., McPhail, S., Stevens, S., & Pearce, F. A. (2023). COVID-19 infection, admission and death and the impact of corticosteroids amongst people with rare autoimmune rheumatic disease during the second wave of covid-19 in England: results from the RECORDER Project. Rheumatology, kead150. https://doi.org/10.1093/rheumatology/kead150

2022

Geetha, D., Kronbichler, A., Rutter, M., Bajpai, D., Menez, S., Weissenbacher, A., Anand, S., Lin, E., Carlson, N., Sozio, S., Fowler, K., Bignall, R., Ducharlet, K., Tannor, E. K., Wijewickrama, E., Hafidz, M. I. A., Tesar, V., Hoover, R., Crews, D., … Luyckx, V. (2022). Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions. Nature Reviews Nephrology, 18(11), 724–737. https://doi.org/10.1038/s41581-022-00618-4

Gumber, L., Gomez, N., Hopkins, G., Tucis, D., Bartlett, L., Ayling, K., Vedhara, K., Steers, G., Chakravorty, M., Rutter, M., Jackson, H., Tighe, P., Ferraro, A., Power, S., Pradère, M.-J., Onion, D., Lanyon, P. C., Pearce, F. A., & Fairclough, L. (2022). Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination. Rheumatology, keac574. https://doi.org/10.1093/rheumatology/keac574

Hannah, J., Gordon, P., Galloway, J., Rutter, M., Peach, E., Rooney, M., Stilwell, P., Grainge, M., Lanyon, P., Bythell, M., & Pearce, F. (2022). Validation of methods to identify people with idiopathic inflammatory myopathies using hospital episode statistics. Rheumatology Advances in Practice, 6. https://doi.org/10.1093/rap/rkac102 

Rutter, M., Pearce, F. A., & Lanyon, P. C. (2022). An uncomfortable truth: the long-term impact of COVID-19 on the clinician-patient relationship. Rheumatology (Oxford, England), 61(SI2). https://doi.org/10.1093/rheumatology/keac193

2021

Chakravorty, M., Pearce, F., Rutter, M., Lanyon, P., Aston, J., Bythell, M., & Stevens, S. (2021). P091 Can use of high cost drugs for rare rheumatic diseases be reliably identified within routinely collected NHS data? Results from a pilot study of rituximab use in vasculitis using data from the National Disease Registration Service (NDRS) and the Registration of Complex Rare Diseases - Exemplars in Rheumatology (RECORDER) project. Rheumatology, 60(Supplement_1). https://doi.org/10.1093/rheumatology/keab247.089

Rutter, A. M., Lanyon, P. C., Grainge, M. J., Hubbard, R., Bythell, M., Stilwell, P., Aston, J., Stevens, S., & Pearce, F. A. (2021). COVID-19 Infection, Admission and Death Amongst People with Rare Autoimmune Rheumatic Disease in England. Results from the RECORDER Project. Rheumatology, 1–19. https://doi.org/10.1093/rheumatology/keab794

Wijayasiri, P., Hayre, J., Nicholson, E. S., Kaye, P., Wilkes, E. A., Evans, J., Aithal, G. P., Jones, G., Pearce, F., & Aravinthan, A. D. (2021). Estimating the clinical prevalence of Wilson’s disease in the UK. JHEP Reports, 3(5), 100329. https://doi.org/https://doi.org/10.1016/j.jhepr.2021.100329

2020

Peach, E., Rutter, M., Lanyon, P., Grainge, M. J., Hubbard, R., Aston, J., Bythell, M., Stevens, S., & Pearce, F. (2020). Risk of death among people with rare autoimmune diseases compared to the general population in England during the 2020 COVID-19 pandemic. Rheumatology, 1–8. https://doi.org/10.1093/rheumatology/keaa855

Pearce, F. A., Griffiths, B., Mukhtyar, C., Al-Jayoussi, R., Watts, R. A., Aston, J., Bythell, M., Stevens, S., & Lanyon, P. C. (2020). P182 Prevalence and mortality of ANCA-associated vasculitis in England. Rheumatology, 59(Supplement_2). https://doi.org/10.1093/rheumatology/keaa111.177

Published Abstracts

Royal Society of Medicine/UKIVAS – Vasculitis: Registries, Pathways and Therapeutics. Rutter, M. RECORDER results: Risk of death during the 2020 UK COVID-19 epidemic and annual influenza seasons among people with vasculitis. November 2020.

Presentations

Royal Society of Medicine/UKIVAS – Vasculitis: From Cell to Service. Rutter, M. Using whole population data to describe COVID-19 outcomes in rare autoimmune rheumatic disease: The RECORDER project collaboration with National Congenital Anomaly and Rare Disease Registration Service (NCARDRS). November 2021.

Public Health Research and Science Conference. Rutter, M. Mortality from COVID-19 Amongst People with Rare Autoimmune Rheumatic Disease in England. Results from the RECORDER Project. May 2021.

Rheumatology Annual Conference 2021 - Rutter, M., Risk of death during the 2020 UK COVID-19 epidemic and annual influenza seasons among people with vasculitis compared to the general population. April 2021

Podcasts

Rheumatology podcast. Bukhari, M., Rutter, M. COVID-19 infection and related death amongst people with RAIRD November 2021 https://academic.oup.com/rheumatology/pages/podcast-archive-2020-2022

Rheumatology podcast. Galloway, J., Rutter, M. Dr Megan Rutter on shielding patterns among patients with lupus. January 2021 https://academic.oup.com/rheumatology/pages/podcast-archive-2020-2022

Rheumatology podcast. Bukhari, M., Pearce, F. The risk of death among RAIRD patients during the COVID-19 pandemic. January 2021 https://academic.oup.com/rheumatology/pages/podcast-archive-2020-2022

Conference abstracts

Groves, D. J., Rutter, M., Lanyon, P. C., Odingo, M., Grainge, M. J., Bythell, M., Aston, J., Stevens, S., Hannah, J. R., Mason, J., & Pearce, F. A. (2022). P300 Comparison of birth rates, gestational diabetes and non-standard maternal deliveries between Takayasu arteritis patients and the England and Wales population. Rheumatology, 61(Supplement_1). https://doi.org/10.1093/rheumatology/keac133.299

Odingo, M., Rutter, M., Lanyon, P., Grainge, M., Groves, D., Bythell, M., Aston, J., Stevens, S., & Pearce, F. (2022). P302 Trends in hospital admissions in patients with ANCA-associated vasculitis before and during the COVID-19 pandemic. Rheumatology, 61(Supplement_1). https://doi.org/10.1093/rheumatology/keac133.301

Rutter, M., Lanyon, P. C., Grainge, M. J., Hubbard, R. B., Peach, E. J., Bythell, M., Aston, J., Stevens, S., & Pearce, F. A. (2021). O24 Risk of death during the 2020 UK COVID-19 epidemic and annual influenza seasons among people with vasculitis compared to the general population: a whole-population study using data from the NDRS and the RECORDER project. Rheumatology, 60(Supplement_1). https://doi.org/10.1093/rheumatology/keab246.023

Pearce, F. A., Rutter, M., Griffiths, B., Mukhtyar, C., Al-Jayoussi, R., Watts, R. A., Aston, J., Bythell, M., Stevens, S., & Lanyon, P. C. (2020). O36 Validation of methods to enable national registration for rare autoimmune rheumatic diseases. Rheumatology, 59(Supplement_2). https://doi.org/10.1093/rheumatology/keaa110.035

Rutter, M., Lanyon, P. C., Bythell, M., Stevens, S., Aston, J., & Pearce, F. A. (2020). P134 Collaborating with the National Congenital Anomaly and Rare Disease Registration Service to estimate national incidence of Kawasaki disease in England. Rheumatology, 59(Supplement_2). https://doi.org/10.1093/rheumatology/keaa111.129

Rutter, M., Lanyon, P. C., Peach, E., Grainge, M. J., Hubbard, R. B., Aston, J., Bythell, M., Stevens, S., & Pearce, F. A. (2021). P054 Risk of death during the 2020 UK COVID-19 epidemic among people with rare diseases compared to the general population. Rheumatology, 60(Supplement_1). https://doi.org/10.1093/rheumatology/keab247.051

Godsave, C., Chakravorty, M., Rutter, M., Lanyon, P., Aston, J., Bythell, M., Stevens, S. and Pearce, F., 2021. Godsave, C., Chakravorty, M., Rutter, M., Lanyon, P., Aston, J., Bythell, M., Stevens, S., & Pearce, F. (2021). POS1412 IDENTIFYING HIGH-COST DRUGS FOR RARE RHEUMATIC DISEASES IN ROUTINELY COLLECTED NHS DATA. RESULTS FROM A PILOT STUDY OF RITUXIMAB USE IN VASCULITIS USING DATA FROM THE NATIONAL DISEASE REGISTRATION SERVICE AND THE REGISTRATION OF COMPLEX RARE DISEASES-EXEMPLARS IN RHEUMATOLOGY (RECORDER) PROJECT. Annals of the Rheumatic Diseases, 80, 989.1-990. https://doi.org/10.1136/annrheumdis-2021-eular.1591